1. Home
  2. FSBW vs NGEN Comparison

FSBW vs NGEN Comparison

Compare FSBW & NGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FS Bancorp Inc.

FSBW

FS Bancorp Inc.

N/A

Current Price

$39.77

Market Cap

312.1M

Sector

Finance

ML Signal

N/A

NGEN

NervGen Pharma Corp. Common stock

N/A

Current Price

$3.99

Market Cap

317.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
FSBW
NGEN
Founded
1936
2017
Country
United States
Canada
Employees
537
N/A
Industry
Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
312.1M
317.6M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
FSBW
NGEN
Price
$39.77
$3.99
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$46.00
N/A
AVG Volume (30 Days)
8.5K
98.1K
Earning Date
04-21-2026
04-02-2026
Dividend Yield
3.13%
N/A
EPS Growth
N/A
N/A
EPS
4.29
N/A
Revenue
$4,612,000.00
N/A
Revenue This Year
$14.94
N/A
Revenue Next Year
$10.47
N/A
P/E Ratio
$8.63
N/A
Revenue Growth
44.80
N/A
52 Week Low
$34.61
$3.55
52 Week High
$44.22
$5.93

Technical Indicators

Market Signals
Indicator
FSBW
NGEN
Relative Strength Index (RSI) 49.28 45.59
Support Level $37.62 $3.69
Resistance Level $40.79 $4.10
Average True Range (ATR) 1.26 0.24
MACD 0.08 0.03
Stochastic Oscillator 72.60 53.99

Price Performance

Historical Comparison
FSBW
NGEN

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

About NGEN NervGen Pharma Corp. Common stock

NervGen Pharma Corp is a clinical-stage biotech company. The company's principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company's initial target indication is spinal cord injury. The company's pipeline products include NVG-291 and NVG-300.

Share on Social Networks: